blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0327769

EP0327769 - Novel neuronotrophic factor [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.09.1993
Database last updated on 11.09.2024
Most recent event   Tooltip21.09.1993Application deemed to be withdrawnpublished on 10.11.1993 [1993/45]
Applicant(s)For all designated states
FIDIA S.p.A.
Via Ponte della Fabbrica 3-A
35031 Abano Terme (Padova) / IT
[N/P]
Former [1989/33]For all designated states
FIDIA S.p.A.
Via Ponte della Fabbrica 3-A
I-35031 Abano Terme (Padova) / IT
Inventor(s)01 / della Valle, Francesco
Via Cerato 14
Padova / IT
[1989/33]
Representative(s)Hirsch, Marc-Roger
Hirsch & Associés
58, Avenue Marceau
75008 Paris / FR
[N/P]
Former [1989/33]Hirsch, Marc-Roger
Cabinet Hirsch 34 rue de Bassano
F-75008 Paris / FR
Application number, filing date88400365.817.02.1988
[1989/33]
Priority number, dateIT1988004761208.02.1988         Original published format: IT 4761288
[1989/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0327769
Date:16.08.1989
Language:EN
[1989/33]
Type: A3 Search report 
No.:EP0327769
Date:18.10.1989
Language:EN
[1989/42]
Search report(s)(Supplementary) European search report - dispatched on:EP29.08.1989
ClassificationIPC:C07K3/02, C07K15/06, A61K37/02
[1989/33]
CPC:
C07K14/475 (EP); A61K35/30 (EP); A61K38/00 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1989/33]
TitleGerman:Neuronotrophischer Faktor[1989/33]
English:Novel neuronotrophic factor[1989/33]
French:Facteur neuronotrophique[1989/33]
File destroyed:12.06.1999
Examination procedure15.11.1989Examination requested  [1990/02]
01.10.1991Despatch of a communication from the examining division (Time limit: M06)
01.04.1992Reply to a communication from the examining division
03.11.1992Despatch of a communication from the examining division (Time limit: M06)
14.05.1993Application deemed to be withdrawn, date of legal effect  [1993/45]
15.06.1993Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1993/45]
Fees paidRenewal fee
22.01.1990Renewal fee patent year 03
27.12.1990Renewal fee patent year 04
01.02.1992Renewal fee patent year 05
17.02.1993Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[AD]DE3213963  (MAX PLANCK GESELLSCHAFT [DE]);
 [E]EP0258111  (FIDIA SPA [IT])
 [A]  - JOURNAL OF NEUROCHEMISTRY, vol. 44, Suppl. 1985, page 36, abstract D, R. DAL TOSO et al.: "Purification and characterization of neuronotrophic activity from bovine caudate nucleus"
 [A]  - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 81, November 1984, Biochemistry, pages 6963-6967, D. GOSPODAROWICZ et al.: "Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: Identity with pituitary fibroblast growth factor"
 [AD]  - PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES USA, vol. 83, May 1986, Neurobiology, pages 3012-3016: P. WALICKE et al.: "Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhance neurite extension"
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.